A holder has filed a Form 144 notice to potentially sell 33,614 shares of common stock through Goldman Sachs & Co. LLC on the NYSE, with an aggregate market value of $7,058,940. The issuer has 261,681,708 shares outstanding, providing context for the size of this planned sale.
The shares to be sold were originally acquired from the issuer as compensation via performance awards on February 22, 2018 (30,113 shares) and February 21, 2012 (3,501 shares), with payment in the form of compensation rather than cash. The seller, identified as the Thomas J. Wilson Revocable Trust dtd 03/13/15, has also sold four prior 16,807‑share blocks of common stock in the past three months, each generating multi‑million‑dollar gross proceeds, and represents that it is not aware of undisclosed material adverse information about the issuer.
Allstate insider plans additional stock sale under Rule 144
A holder of Allstate common stock has filed a Form 144 indicating an intention to sell 3,786 shares through Fidelity Brokerage Services on the NYSE. The planned sale, dated 11/28/2025, relates to shares acquired the same day via an option granted on 02/11/2016 and paid for in cash. The filing notes 261,681,708 Allstate common shares outstanding, giving context for the size of this transaction.
Over the prior three months, the same seller, Suren K. Gupta, reported multiple open‑market sales of Allstate common stock, including 1,400 shares on 11/14/2025, 400 shares on 11/17/2025, 21,871 shares on 11/21/2025, 600 shares on 11/24/2025, and 750 shares on 11/26/2025, with disclosed gross proceeds for each trade. The signer represents that they are not aware of undisclosed material adverse information about Allstate when making or planning these sales.
The Allstate Corporation executive files Form 4 for option exercise and share sale. On 11/24/2025, the President, Enterprise Solutions of Allstate exercised employee stock options for 600 shares of common stock at an exercise price of $62.32 per share and then sold 600 shares of common stock in an open-market transaction at a weighted average price of $215.0175 per share. These trades were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. Following the transactions, the reporting person beneficially owned 100,646 shares directly, 1,329 shares through a 401(k) plan, 7 shares through VVG Holdings LLC, and 24,129 employee stock options.
The Allstate Corporation (ALL) reported an insider equity transaction by its President, Enterprise Solutions, Suren Gupta. On 11/21/2025, he exercised an employee stock option for 21,871 shares of common stock at an exercise price of $62.32 per share and, on the same date, sold 21,871 shares of common stock in an open-market transaction at a weighted average price of $215.2125 per share.
The transactions were made under a pre-arranged Rule 10b5-1(c) trading plan adopted on June 9, 2025. After these transactions, he beneficially owned 100,646 shares of Allstate common stock directly, plus 1,329 shares through a 401(k) plan and 7 shares through VVG Holdings LLC, as reported in the filing.
The Allstate Corporation has filed a Form S-8 to register deferred compensation obligations issued under its Deferred Compensation Plan for Independent Contractor Exclusive Agents. The plan allows eligible exclusive insurance agents and exclusive financial specialists, who are compensated as independent contractors by Allstate subsidiaries, to defer portions of their compensation.
Deferred amounts are recorded by book entry in notional accounts and allocated among investment options chosen by participants, currently mirroring certain options in the Allstate 401(k) Savings Plan, for accounting purposes only. The obligations are unfunded, unsecured general obligations of Allstate, ranking equally with its other unsecured and unsubordinated indebtedness and payable in U.S. dollars, so participants are exposed to Allstate’s general credit risk.
The plan restricts early distributions to limited circumstances such as separation from service, hardship or unforeseeable financial emergency under specified tax rules, certain in-service withdrawals, or plan termination. Allstate may amend or terminate the plan, but cannot reduce previously deferred compensation or related accruals. The filing also outlines existing Delaware-law based indemnification protections and insurance coverage for directors and officers.
Allstate (symbol ALL) insider Suren K. Gupta has filed a Form 144 notice to sell 600 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 129,010.50 and an approximate sale date of 11/24/2025.
The 600 shares were acquired on 11/24/2025 via an option originally granted on 02/11/2016 and paid for in cash. The notice also lists recent sales over the past three months by the same seller: 1,400 shares on 11/14/2025 for gross proceeds of 301,030.94, 400 shares on 11/17/2025 for 86,086.00, and 21,871 shares on 11/21/2025 for 4,706,912.59.
An insider of the company with ticker ALL has filed a Rule 144 notice to sell 21,871 common shares through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $4,706,913.07. These shares are listed as being acquired on 11/21/2025 via a stock option originally granted on 02/11/2016, with payment noted as cash. The filing also reports that the same insider sold 1,400 common shares on 11/14/2025 for gross proceeds of $301,030.94 and 400 common shares on 11/17/2025 for $86,086.00 during the prior three months.
The Allstate Corporation reported a planned change in its board leadership. Long-time director Gregg M. Sherrill, who has served on the board since 2017 and as Lead Director since 2021, will retire from the board effective November 21, 2025. The company states that his retirement does not involve any disagreement with Allstate.
Upon Mr. Sherrill’s retirement, director Richard T. Hume, a board member since 2020, will become the new Lead Director effective the same date. This filing focuses solely on these governance changes and does not report any financial results or major transactions.
The Allstate Corporation filed a Form 8-K to provide a Regulation FD disclosure about its October 2025 monthly release. The company states that a press release announcing estimated catastrophe losses and policies in force for October 2025 has been posted on allstateinvestors.com and is attached as Exhibit 99.
The press release is dated November 20, 2025 and is being furnished, not filed, under Item 7.01, which affects how it is treated for certain securities law purposes. The filing also lists Allstate’s common stock and various preferred and subordinated securities traded on the New York Stock Exchange.
The Allstate Corporation (ALL) reported that its Chairman, President & CEO, Thomas J. Wilson, sold Allstate common stock in open-market transactions on 11/17/2025. He sold 15,370 shares at a weighted average price of $213.1159, 1,137 shares at $213.9619, and 300 shares at $214.7028, with actual prices in disclosed ranges for each trade. These sales were made under a Rule 10b5-1 trading plan adopted on June 27, 2025, which is a pre-arranged plan for systematic stock sales. Following the reported transactions, Wilson beneficially owned 161,619.491 Allstate shares directly, in addition to multiple indirect holdings through various GRATs, a 401(k) plan, and a remainder trust.